<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34763986</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1476</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Auris, nasus, larynx</Title>
          <ISOAbbreviation>Auris Nasus Larynx</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Therapeutic efficacy of selective intraarterial chemoradiotherapy with docetaxel and nedaplatin for human papilloma virus-negative oropharyngeal cancer.</ArticleTitle>
        <Pagination>
          <StartPage>468</StartPage>
          <EndPage>476</EndPage>
          <MedlinePgn>468-476</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anl.2021.10.014</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0385-8146(21)00258-3</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Human papilloma virus-negative oropharyngeal cancer has not achieved satisfactory outcomes compared with those of human papilloma virus-positive oropharyngeal cancer. This study evaluated the therapeutic efficacy of selective intraarterial chemoradiotherapy with the docetaxel and nedaplatin regimen for human papilloma virus-negative oropharyngeal cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-two consecutive patients with human papilloma virus-negative oropharyngeal cancer who had undergone selective intraarterial chemoradiotherapy were retrospectively analyzed. The primary tumor and whole neck were irradiated (50 Gy). Subsequently, the primary site and metastatic lymph nodes were boosted by 20 Gy. The intraarterial chemotherapy regimen comprised a combination of nedaplatin (80 mg/m<sup>2</sup>) and docetaxel (60 mg/m<sup>2</sup>), which was initially administered at the start of radiotherapy and was given every 4 weeks for three sessions. Each intraarterial dose of an anticancer agent was determined according to the percentage of the tumor volume supplied by the target artery to the total tumor volume, which was intraoperatively measured via cone-beam computed tomography. The outcome measures were locoregional control, disease-free survival, and overall survival rates and adverse events. Statistical analyses were performed using the Kaplan-Meier method.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median follow-up period was 59 (range, 15-103) months. The T stage was T1/T2 in 5 patients (23%), T3 in 5 patients (23%), and T4 in 12 patients (54%). Cervical lymph node metastasis was staged as ≥N2c in 7 (32%) patients. Complete response was achieved in all patients at the first imaging examination after intraarterial chemoradiotherapy. The 5-year locoregional control, disease-free survival, and overall survival rates were 96% (95% confidence interval, 0.72-0.99), 91% (95% confidence interval, 0.68-0.98), and 100% (95% confidence interval, not available), respectively. Regarding serious acute adverse events, grade 4 laryngeal edema and leukopenia were observed in 1 (5%) and 11 patients (50%), respectively. No other serious acute adverse events were observed.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Selective intraarterial chemoradiotherapy with docetaxel and nedaplatin has the potential to achieve favorable locoregional control, disease-free survival, and overall survival rates in human papilloma virus-negative oropharyngeal cancer.</AbstractText>
          <CopyrightInformation>Copyright © 2021. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Heianna</LastName>
            <ForeName>Joichi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan. Electronic address: anna1150@med.u-ryukyu.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Makino</LastName>
            <ForeName>Wataru</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirakawa</LastName>
            <ForeName>Hitoshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agena</LastName>
            <ForeName>Shinya</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomita</LastName>
            <ForeName>Hayato</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan; Department of Radiology, St Marianna University School of Medicine, 2-6-1, Sugao, Miyamae, Kawasaki, Kanagawa 216-8511, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ariga</LastName>
            <ForeName>Takuro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishikawa</LastName>
            <ForeName>Kazuki</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takehara</LastName>
            <ForeName>Shota</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kusada</LastName>
            <ForeName>Takeaki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maemoto</LastName>
            <ForeName>Hitoshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maeda</LastName>
            <ForeName>Hiroyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murayama</LastName>
            <ForeName>Sadayuki</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Graduate School of Medical Science, University of The Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Auris Nasus Larynx</MedlineTA>
        <NlmUniqueID>7708170</NlmUniqueID>
        <ISSNLinking>0385-8146</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009944">Organoplatinum Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>15H5577CQD</RegistryNumber>
          <NameOfSubstance UI="D000077143">Docetaxel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8UQ3W6JXAN</RegistryNumber>
          <NameOfSubstance UI="C053989">nedaplatin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>Q20Q21Q62J</RegistryNumber>
          <NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059248" MajorTopicYN="N">Chemoradiotherapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002945" MajorTopicYN="Y">Cisplatin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077143" MajorTopicYN="N">Docetaxel</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009944" MajorTopicYN="N">Organoplatinum Compounds</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009959" MajorTopicYN="Y">Oropharyngeal Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D027383" MajorTopicYN="N">Papillomaviridae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Human papilloma virus</Keyword>
        <Keyword MajorTopicYN="N">Intraarterial chemotherapy</Keyword>
        <Keyword MajorTopicYN="N">Oropharyngeal cancer</Keyword>
        <Keyword MajorTopicYN="N">Radiotherapy</Keyword>
      </KeywordList>
      <CoiStatement>Declarations of Competing Interest None of the authors reported a conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34763986</ArticleId>
        <ArticleId IdType="doi">10.1016/j.anl.2021.10.014</ArticleId>
        <ArticleId IdType="pii">S0385-8146(21)00258-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
